Logo image of GLBS

GLOBUS MARITIME LIMITED (GLBS) Stock Fundamental Analysis

NASDAQ:GLBS - Nasdaq - MHY272651263 - Common Stock - Currency: USD

1.13  -0.02 (-1.31%)

After market: 1.15 +0.02 (+1.77%)

Fundamental Rating

2

Taking everything into account, GLBS scores 2 out of 10 in our fundamental rating. GLBS was compared to 36 industry peers in the Marine Transportation industry. GLBS has a bad profitability rating. Also its financial health evaluation is rather negative. GLBS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year GLBS has reported negative net income.
In the past year GLBS had a positive cash flow from operations.
GLBS had positive earnings in 4 of the past 5 years.
In multiple years GLBS reported negative operating cash flow during the last 5 years.
GLBS Yearly Net Income VS EBIT VS OCF VS FCFGLBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M -80M

1.2 Ratios

With a Return On Assets value of -0.24%, GLBS is not doing good in the industry: 69.44% of the companies in the same industry are doing better.
GLBS has a Return On Equity of -0.43%. This is in the lower half of the industry: GLBS underperforms 69.44% of its industry peers.
Industry RankSector Rank
ROA -0.24%
ROE -0.43%
ROIC N/A
ROA(3y)4.39%
ROA(5y)0.23%
ROE(3y)5.82%
ROE(5y)-2.72%
ROIC(3y)N/A
ROIC(5y)N/A
GLBS Yearly ROA, ROE, ROICGLBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

In the last couple of years the Profit Margin of GLBS has declined.
In the last couple of years the Operating Margin of GLBS has declined.
GLBS has a Gross Margin (49.97%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of GLBS has grown nicely.
The Profit Margin and Operating Margin are not available for GLBS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.97%
OM growth 3Y-52.91%
OM growth 5YN/A
PM growth 3Y-67.02%
PM growth 5YN/A
GM growth 3Y-6.01%
GM growth 5Y7.16%
GLBS Yearly Profit, Operating, Gross MarginsGLBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

More info and screens

3

2. Health

2.1 Basic Checks

GLBS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GLBS has about the same amount of shares outstanding.
GLBS has more shares outstanding than it did 5 years ago.
GLBS has a worse debt/assets ratio than last year.
GLBS Yearly Shares OutstandingGLBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
GLBS Yearly Total Debt VS Total AssetsGLBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

GLBS has an Altman-Z score of -0.18. This is a bad value and indicates that GLBS is not financially healthy and even has some risk of bankruptcy.
GLBS has a worse Altman-Z score (-0.18) than 75.00% of its industry peers.
GLBS has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of GLBS (0.43) is better than 63.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z -0.18
ROIC/WACCN/A
WACC7.71%
GLBS Yearly LT Debt VS Equity VS FCFGLBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

GLBS has a Current Ratio of 1.70. This is a normal value and indicates that GLBS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.70, GLBS is doing good in the industry, outperforming 61.11% of the companies in the same industry.
GLBS has a Quick Ratio of 1.65. This is a normal value and indicates that GLBS is financially healthy and should not expect problems in meeting its short term obligations.
GLBS has a better Quick ratio (1.65) than 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.65
GLBS Yearly Current Assets VS Current LiabilitesGLBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for GLBS have decreased strongly by -133.33% in the last year.
GLBS shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -72.55% yearly.
The Revenue has grown by 17.91% in the past year. This is quite good.
GLBS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.42% yearly.
EPS 1Y (TTM)-133.33%
EPS 3Y-72.55%
EPS 5YN/A
EPS Q2Q%-600%
Revenue 1Y (TTM)17.91%
Revenue growth 3Y-7.02%
Revenue growth 5Y17.42%
Sales Q2Q%11.75%

3.2 Future

GLBS is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -270.54% yearly.
GLBS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.03% yearly.
EPS Next Y-2650%
EPS Next 2Y-270.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.7%
Revenue Next 2Y14.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
GLBS Yearly Revenue VS EstimatesGLBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
GLBS Yearly EPS VS EstimatesGLBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2021 2022 2023 2024 2025 2026 0 500 1K 1.5K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GLBS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GLBS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GLBS Price Earnings VS Forward Price EarningsGLBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, GLBS is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.81
GLBS Per share dataGLBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8

4.3 Compensation for Growth

A cheap valuation may be justified as GLBS's earnings are expected to decrease with -270.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-270.54%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GLBS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLOBUS MARITIME LIMITED

NASDAQ:GLBS (7/18/2025, 8:00:01 PM)

After market: 1.15 +0.02 (+1.77%)

1.13

-0.02 (-1.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)06-16 2025-06-16/amc
Earnings (Next)09-10 2025-09-10
Inst Owners7.16%
Inst Owner Change0%
Ins Owners1.67%
Ins Owner ChangeN/A
Market Cap23.26M
Analysts82.86
Price Target3.06 (170.8%)
Short Float %3.58%
Short Ratio12.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.41%
Min EPS beat(2)-8.93%
Max EPS beat(2)23.75%
EPS beat(4)3
Avg EPS beat(4)94.39%
Min EPS beat(4)-8.93%
Max EPS beat(4)292.16%
EPS beat(8)6
Avg EPS beat(8)56.46%
EPS beat(12)8
Avg EPS beat(12)38.92%
EPS beat(16)11
Avg EPS beat(16)63.76%
Revenue beat(2)0
Avg Revenue beat(2)-13.7%
Min Revenue beat(2)-21.03%
Max Revenue beat(2)-6.37%
Revenue beat(4)1
Avg Revenue beat(4)-3.36%
Min Revenue beat(4)-21.03%
Max Revenue beat(4)19.61%
Revenue beat(8)2
Avg Revenue beat(8)-8.3%
Revenue beat(12)5
Avg Revenue beat(12)-0.99%
Revenue beat(16)8
Avg Revenue beat(16)3.42%
PT rev (1m)-25%
PT rev (3m)-25%
EPS NQ rev (1m)-500%
EPS NQ rev (3m)-500%
EPS NY rev (1m)-177.78%
EPS NY rev (3m)-177.78%
Revenue NQ rev (1m)-26.67%
Revenue NQ rev (3m)-26.67%
Revenue NY rev (1m)-21.27%
Revenue NY rev (3m)-21.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.65
P/FCF N/A
P/OCF 2.17
P/B 0.13
P/tB 0.13
EV/EBITDA 4.81
EPS(TTM)-0.04
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)-3.66
FCFYN/A
OCF(TTM)0.52
OCFY46%
SpS1.74
BVpS8.5
TBVpS8.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.24%
ROE -0.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.97%
FCFM N/A
ROA(3y)4.39%
ROA(5y)0.23%
ROE(3y)5.82%
ROE(5y)-2.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-52.91%
OM growth 5YN/A
PM growth 3Y-67.02%
PM growth 5YN/A
GM growth 3Y-6.01%
GM growth 5Y7.16%
F-Score4
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA 10.23
Cap/Depr 1156.82%
Cap/Sales 240.44%
Interest Coverage N/A
Cash Conversion 144.22%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 1.65
Altman-Z -0.18
F-Score4
WACC7.71%
ROIC/WACCN/A
Cap/Depr(3y)573.4%
Cap/Depr(5y)866.84%
Cap/Sales(3y)101.87%
Cap/Sales(5y)125.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.33%
EPS 3Y-72.55%
EPS 5YN/A
EPS Q2Q%-600%
EPS Next Y-2650%
EPS Next 2Y-270.54%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.91%
Revenue growth 3Y-7.02%
Revenue growth 5Y17.42%
Sales Q2Q%11.75%
Revenue Next Year1.7%
Revenue Next 2Y14.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y98.36%
EBIT growth 3Y-56.21%
EBIT growth 5YN/A
EBIT Next Year275.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-690.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-23.7%
OCF growth 3Y-18.37%
OCF growth 5Y121.85%